Retrospective resistance analysis of pathogens causing bacterial infections of the anterior segment in 2018–2024 and rational antibacterial therapy considerations
Ophthalmology Reports · 31.03.2026 · 19 (1) · 51-60
DOI: 10.17816/ov702004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology Reports, online erschienen am 31.03.2026. Verfasst von Oleg A. Frolov und 5 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Antibiotic resistance remains a common challenge in treatment of infectious diseases, including ocular ones. Resistance of ocular pathogens can hinder choosing an antimicrobial agent and reduce the effectiveness of prescribed antibacterial therapy. Therefore, constant monitoring of pathogen susceptibility is an important step in tackling increasing antibiotic resistance. AIM: This study aimed to identify causative agents of bacterial infections of the eyelid and conjunctiva and analyze their susceptibility to antibacterial agents in patients aged over 3 years. METHODS: We analyzed the data of 20,607 conjunctival microbiome tests in patients with bacterial infections of the eyelid and conjunctiva who visited an outpatient department of the St. Petersburg Diagnostic Center No. 7 in 2018–2024. Conjunctival swabs were taken from all patients to identify pathogens and determine their antimicrobial susceptibility. Microorganisms were isolated and identified by microscopic, cultural, and biochemical methods. RESULTS: Bacterial infections of the anterior segment were caused by Gram-positive microorganisms in 46% of cases, mainly by Staphylococcus epidermidis with a detection rate of 32.5%–37.9%, followed by Gram-negative microorganisms identified in 34% of cases, of which Klebsiella pneumoniae was the most common with a detection rate of 16%–23.5%. Mixed Gram-positive and Gram-negative flora was identified in the remaining 20% of cases. Data analysis revealed high resistance of all pathogens to azithromycin, with S. epidermidis resistance of up to 64%. All isolated pathogens were most susceptible (up to 99%) to fourth-generation fluoroquinolones, namely to moxifloxacin. CONCLUSION: Based on the data obtained, moxifloxacin products may be recommended for ophthalmological use as an agent of choice for the treatment of bacterial infections of the eyelids and conjunctiva.
Zitieren
APA
Frolov, O. A., Polovinkina, G. V., Gyamdzhyan, K. A., Pokrovskii, A. S., Khramtsova, M. A., & Loginevskaya, M. G. (2026). Retrospective resistance analysis of pathogens causing bacterial infections of the anterior segment in 2018–2024 and rational antibacterial therapy considerations. Ophthalmology Reports, 19(1), 51-60. https://doi.org/10.17816/ov702004
Vancouver
Frolov OA, Polovinkina GV, Gyamdzhyan KA, Pokrovskii AS, Khramtsova MA, Loginevskaya MG. Retrospective resistance analysis of pathogens causing bacterial infections of the anterior segment in 2018–2024 and rational antibacterial therapy considerations. Ophthalmology Reports. 2026;19(1):51-60. doi:10.17816/ov702004
BibTeX
@article{Frolov2026,
author = {Frolov, Oleg A. and Polovinkina, Galina V. and Gyamdzhyan, Karine A. and Pokrovskii, Andrei S. and Khramtsova, Marina A. and Loginevskaya, Marina G.},
title = {Retrospective resistance analysis of pathogens causing bacterial infections of the anterior segment in 2018–2024 and rational antibacterial therapy considerations},
journal = {Ophthalmology Reports},
year = {2026},
volume = {19},
number = {1},
pages = {51--60},
doi = {10.17816/ov702004}
}
EUVIMED